Spruce Biosciences Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, Spruce Biosciences stock has a consensus rating of "Strong Buy" and an average price target of $149.71. The average 1-year stock price forecast is 185.92% higher than the current stock price, while the lowest is $120 (+129.18%) and the highest is $230 (+339.27%).

Price Target: $149.71 (+185.92%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$120	$149.71	$140	$230
Change	+129.18%	+185.92%	+167.38%	+339.27%

Analyst Ratings

The average analyst rating for Spruce Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	3	3	3	4	4	6
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	5	5	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Debjit Chattopadhyay Guggenheim	Guggenheim	Buy Initiates $123	Buy	Initiates	$123	+134.91%	Jun 16, 2026
Catherine Novack JonesTrading	JonesTrading	Buy Initiates $135	Buy	Initiates	$135	+157.83%	Jun 8, 2026
Ram Selvaraju H.C. Wainwright	H.C. Wainwright	Buy Reiterates $200 → $150	Buy	Reiterates	$200 → $150	+186.48%	Jun 1, 2026
Leland Gershell Oppenheimer	Oppenheimer	Buy Reiterates $283 → $230	Buy	Reiterates	$283 → $230	+339.27%	May 27, 2026
Joseph Schwartz Leerink Partners	Leerink Partners	Buy Reiterates $140 → $120	Buy	Reiterates	$140 → $120	+129.18%	May 15, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

78.19M

EPS This Year

-25.64

from -50.83

EPS Next Year

4.95

from -25.64

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	10.09M	4.91M	-	-
Gross Profit	-	-35.20M	-39.34M	-41.51M	-13.62M	-
Gross Margin	-	-	-389.96%	-845.18%	-	90.00%
Operating Income	-42.07M	-47.28M	-51.99M	-56.15M	-28.61M	-52.07M
Net Income	-42.29M	-46.18M	-47.92M	-53.04M	-38.97M	-52.41M
EPS	-	-	-	-	-50.83	-25.64
Free Cash Flow	-20.70M	-25.55M	-17.52M	-38.75M	-16.67M	-48.07M
No. Analysts	-	-	-	-	-	7

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Revenue Growth	2027	2028
High	-
Avg	-
Low	-

EPS Forecast

EPS	2026	2027	2028
High	-22.16
Avg	-25.64
Low	-33.25

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-